Urinary Angiotensinogen and Progression of Chronic Kidney Disease: Results from KNOW-CKD Studyopen access
- Authors
- Suh, Sang Heon; Oh, Tae Ryom; Choi, Hong Sang; Yang, Eun Mi; Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Oh, Kook-Hwan; Jung, Ji Yong; Hyun, Young Youl; Kim, Soo Wan
- Issue Date
- Sep-2022
- Publisher
- MDPI
- Keywords
- angiotensinogen; biomarker; chronic kidney disease; end-stage renal disease; estimated glomerular filtration rate
- Citation
- BIOMOLECULES, v.12, no.9
- Journal Title
- BIOMOLECULES
- Volume
- 12
- Number
- 9
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/85867
- DOI
- 10.3390/biom12091280
- ISSN
- 2218-273X
- Abstract
- The prognostic value of urinary angiotensinogen (UAGT) in patients with chronic kidney disease (CKD) has not been completely evaluated, although the association of UAGT with renal outcomes has been suggested in specific subsets of CKD. In the present study, to investigate the association of UAGT with renal outcomes in patients with non-dialysis CKD irrespective of the primary cause, a total of 1688 subjects from the Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) were prospectively analyzed. The subjects were divided into the quintile by UAGT to urine creatinine ratio (UAGT/Cr) level. The primary outcomes of interest were composite renal event, which included decline in kidney function and onset of end-stage renal disease during follow-up periods. The median follow-up duration was 6.257 years. Cox regression model analysis unveiled that the risk of composite renal event was significantly higher in the fifth quintile (adjusted hazard ratio 1.528, 95% confidence interval 1.156 to 2.021) compared to that of the first quartile. The association between high UAGT/Cr level and adverse renal outcome remained consistent in sensitivity analyses, including the analysis of the cause-specific hazard model. Subgroup analyses revealed that the association of UAGT level with renal outcomes is modified by certain clinical contexts, such as BMI and albuminuria. In conclusion, high UAGT level is associated with adverse renal outcomes in patients with non-dialysis CKD. Further studies are warranted to elaborate and expand the predictive role of UAGT as a biomarker for renal outcomes in CKD.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/85867)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.